Aiforia Technologies Oyj/€AIFORIA
1D1W1MYTD1Y5YMAX
Capital at risk
About Aiforia Technologies Oyj
Aiforia Technologies Oyj, established in 2013 and headquartered in Helsinki, Finland, develops deep learning artificial intelligence (AI) software for pathology image analysis. The company's core products include AI-supported diagnostic suites for breast, lung, and prostate cancers, as well as Aiforia Create, a platform enabling users to develop and validate proprietary AI models for 2D image analysis. Aiforia serves a global clientele, including pharmaceutical and biotechnology companies, contract research organizations, clinical laboratories, and academic institutions. The company operates internationally, with offices in Cambridge, Massachusetts, and Rochester, Minnesota, and representatives across Europe and North America. Aiforia's strategic focus includes expanding its clinical and preclinical offerings, forming strategic partnerships, and achieving positive cash flow from operating activities. (,)
- Ticker
- €AIFORIA
- Sector
- Health
- Primary listing
- XHEL
- Employees
- 67
- Headquarters
- Helsinki, Finland
- Website
- www.aiforia.com
AIFORIA Metrics
BasicAdvanced
€34M
-
-€0.42
0.12
-
Price and volume
Market cap
€34M
Beta
0.12
52-week high
€2.67
52-week low
€1.76
Average daily volume
65K
Financial strength
Current ratio
2.007
Quick ratio
2.007
Long term debt to equity
0.294
Total debt to equity
0.439
Profitability
EBITDA (TTM)
-13.25
Gross margin (TTM)
-161.11%
Net profit margin (TTM)
-475.08%
Operating margin (TTM)
-463.29%
Effective tax rate (TTM)
-0.17%
Revenue per employee (TTM)
€40,000
Management effectiveness
Return on assets (TTM)
-28.27%
Return on equity (TTM)
-77.45%
Valuation
Price to revenue (TTM)
10.075
Price to book
2.04
Price to tangible book (TTM)
45.4
Price to free cash flow (TTM)
-2.276
Free cash flow yield (TTM)
-43.93%
Free cash flow per share (TTM)
-0.39
Growth
Revenue change (TTM)
0.63%
Earnings per share change (TTM)
-3.20%
3-year revenue growth (CAGR)
16.41%
3-year earnings per share growth (CAGR)
-8.88%
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.